| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A brain problem with Listeria monocytogenes
|
Boully, Amélie
|
|
|
22 |
2 |
p. 296
|
artikel
|
| 2 |
Acanthamoeba castellanii encephalitis in a patient with AIDS: a case report and literature review
|
Damhorst, Gregory L
|
|
|
22 |
2 |
p. e59-e65
|
artikel
|
| 3 |
Alexandra King—promoting Indigenous self-determination
|
Kazi, Farooq
|
|
|
22 |
2 |
p. 178
|
artikel
|
| 4 |
A new strategy is required for malaria elimination in Africa
|
Balakrishnan, Vijay Shankar
|
|
|
22 |
2 |
p. 170-171
|
artikel
|
| 5 |
Antimicrobial use and resistance in England, 2020–21
|
Venkatesan, Priya
|
|
|
22 |
2 |
p. 173
|
artikel
|
| 6 |
Atypical imported loiasis characterised by recurrent anaemia in a patient from China
|
Luo, Xiaocheng
|
|
|
22 |
2 |
p. 295
|
artikel
|
| 7 |
Community-acquired pneumonia: is less more?
|
Peghin, Maddalena
|
|
|
22 |
2 |
p. 159-161
|
artikel
|
| 8 |
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
|
Singanayagam, Anika
|
|
|
22 |
2 |
p. 183-195
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2022; 22: 250–64
|
|
|
|
22 |
2 |
p. e41
|
artikel
|
| 10 |
Correction to Lancet Infect Dis 2022; 22: 31
|
|
|
|
22 |
2 |
p. e41
|
artikel
|
| 11 |
Correction to Lancet Infect Dis 2022; 22: 284–94
|
|
|
|
22 |
2 |
p. e41
|
artikel
|
| 12 |
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study
|
Penn-Nicholson, Adam
|
|
|
22 |
2 |
p. 242-249
|
artikel
|
| 13 |
Discordant results of tests for tuberculosis reconsidered
|
Arend, Sandra M
|
|
|
22 |
2 |
p. 164
|
artikel
|
| 14 |
Discordant results of tests for tuberculosis reconsidered – Authors' reply
|
Ho, Christine S
|
|
|
22 |
2 |
p. 164-165
|
artikel
|
| 15 |
Effect of change in vaccine schedule on pertussis epidemiology in France: a modelling and serological study
|
Paireau, Juliette
|
|
|
22 |
2 |
p. 265-273
|
artikel
|
| 16 |
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019
|
|
|
|
22 |
2 |
p. 222-241
|
artikel
|
| 17 |
Has the COVID-19 pandemic increased tuberculosis mortality?
|
Dowdy, David W
|
|
|
22 |
2 |
p. 165-166
|
artikel
|
| 18 |
Illuminating the shadows in a Brazilian AIDS community
|
Harding, Emilia
|
|
|
22 |
2 |
p. 182
|
artikel
|
| 19 |
Implications of bedaquiline-resistant tuberculosis
|
Decroo, Tom
|
|
|
22 |
2 |
p. 166-167
|
artikel
|
| 20 |
Implications of bedaquiline-resistant tuberculosis
|
Mishra, Gyanshankar P
|
|
|
22 |
2 |
p. 166
|
artikel
|
| 21 |
Inequalities hinder infectious disease control
|
Samarasekera, Udani
|
|
|
22 |
2 |
p. 172
|
artikel
|
| 22 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
22 |
2 |
p. 175
|
artikel
|
| 23 |
Knowledge gaps in the epidemiology of severe dengue impede vaccine evaluation
|
Sharp, Tyler M
|
|
|
22 |
2 |
p. e42-e51
|
artikel
|
| 24 |
Laura Hammitt—prioritising Native American health
|
Kirby, Tony
|
|
|
22 |
2 |
p. 179
|
artikel
|
| 25 |
Malcolm Molyneux
|
Bagcchi, Sanjeet
|
|
|
22 |
2 |
p. 177
|
artikel
|
| 26 |
Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in China, 2016–20
|
Liu, Congcong
|
|
|
22 |
2 |
p. 167-168
|
artikel
|
| 27 |
Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial
|
Schweitzer, Valentijn A
|
|
|
22 |
2 |
p. 274-283
|
artikel
|
| 28 |
Ordinary people in extraordinary times
|
Paterson, Brianna
|
|
|
22 |
2 |
p. 180
|
artikel
|
| 29 |
Polio amid a humanitarian crisis in Afghanistan: challenges and recommendations
|
Tharwani, Zoaib Habib
|
|
|
22 |
2 |
p. 168-169
|
artikel
|
| 30 |
Polio eradication: what kind of world do we want?
|
Thompson, Kimberly M
|
|
|
22 |
2 |
p. 161-163
|
artikel
|
| 31 |
Prevention of host-to-host transmission by SARS-CoV-2 vaccines
|
Mostaghimi, Darius
|
|
|
22 |
2 |
p. e52-e58
|
artikel
|
| 32 |
Remdesivir, on the road to DisCoVeRy
|
Gyselinck, Iwein
|
|
|
22 |
2 |
p. 153-155
|
artikel
|
| 33 |
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|
Ader, Florence
|
|
|
22 |
2 |
p. 209-221
|
artikel
|
| 34 |
Research in brief
|
Devi, Sharmila
|
|
|
22 |
2 |
p. 176
|
artikel
|
| 35 |
Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa
|
Cooper, Laura V
|
|
|
22 |
2 |
p. 284-294
|
artikel
|
| 36 |
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
|
Xia, ShengLi
|
|
|
22 |
2 |
p. 196-208
|
artikel
|
| 37 |
Sex-disaggregated tuberculosis data call for gender-equitable tuberculosis control
|
Rowley, Elizabeth
|
|
|
22 |
2 |
p. 155-156
|
artikel
|
| 38 |
Survival sex: “I have no option left”
|
Becker, Stephanie C
|
|
|
22 |
2 |
p. 181
|
artikel
|
| 39 |
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis
|
Krutikov, Maria
|
|
|
22 |
2 |
p. 250-264
|
artikel
|
| 40 |
The origin of SARS-CoV-2 variants of concern
|
Burki, Talha
|
|
|
22 |
2 |
p. 174-175
|
artikel
|
| 41 |
Time for Africa to future-proof, starting with COVID-19
|
The Lancet Infectious Diseases,
|
|
|
22 |
2 |
p. 151
|
artikel
|
| 42 |
Timing is everything when it comes to pertussis vaccination
|
Perkins, T Alex
|
|
|
22 |
2 |
p. 158-159
|
artikel
|
| 43 |
What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
|
Wilder-Smith, Annelies
|
|
|
22 |
2 |
p. 152-153
|
artikel
|
| 44 |
Xpert MTB/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin
|
Mvelase, Nomonde R
|
|
|
22 |
2 |
p. 156-157
|
artikel
|
Tijdschrift beschrijving